A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Escalating Study to Assess the Pharmacokinetics and Pharmacodynamics of MTR105 in Cardiac Surgery Induced Hypotension Patients During Weaning Off Cardiopulmonary Bypass

Trial Profile

A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Escalating Study to Assess the Pharmacokinetics and Pharmacodynamics of MTR105 in Cardiac Surgery Induced Hypotension Patients During Weaning Off Cardiopulmonary Bypass

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2015

At a glance

  • Drugs MTR 104 (Primary)
  • Indications Hypotension
  • Focus Pharmacodynamics
  • Sponsors Meditor Pharmaceuticals
  • Most Recent Events

    • 03 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top